Trials / Conditions / Infections, Respiratory Tract

Infections, Respiratory Tract

19 registered clinical trials studyying Infections, Respiratory Tract — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated from Patients with Hospit NCT06628076	Sohag University	—
Completed	Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Oti NCT04600752	GlaxoSmithKline	Phase 4
Withdrawn	An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and Flu NCT02678234	GlaxoSmithKline	Phase 3
Withdrawn	An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and Flu NCT02730364	GlaxoSmithKline	Phase 3
Completed	A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution NCT02688361	GlaxoSmithKline	Phase 1
Completed	Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers NCT02257398	GlaxoSmithKline	Phase 1
Completed	Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1 NCT02169583	GlaxoSmithKline	Phase 1
Completed	A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Sing NCT02000765	GlaxoSmithKline	Phase 1
Completed	This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK21 NCT01706315	GlaxoSmithKline	Phase 1
Completed	Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV Doses NCT01615796	GlaxoSmithKline	Phase 1
Terminated	A Study to Identify and Characterise Bacteria Causing Chronic Cough Among Children in United Kingdom NCT01292213	GlaxoSmithKline	—
Completed	Probiotics in Respiratory Tract Infections in Children NCT01510938	Lviv National Medical University	Phase 2
Completed	A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers NCT02202187	GlaxoSmithKline	Phase 1
Completed	Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study NCT01353768	GlaxoSmithKline	—
Completed	Bioequivalence Study of an Amoxicillin-Clavulanic NCT01772238	GlaxoSmithKline	Phase 1
Completed	Bioequivalence Study of Cephalexin Suspension 250 NCT01767571	GlaxoSmithKline	Phase 1
Completed	Bioequivalence Study of Cephalexin Suspension 125 NCT01767532	GlaxoSmithKline	Phase 1
Completed	Bioequivalence Study of Cephalexin Tablets 1g NCT01767584	GlaxoSmithKline	Phase 1
Completed	Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients NCT00354965	GlaxoSmithKline	Phase 1